| Literature DB >> 35286335 |
Maris Brenn-White1, Bonnie L Raphael2,3, Ny Aina Tiana Rakotoarisoa4, Sharon L Deem1.
Abstract
Madagascar's radiated tortoises (Astrochelys radiata) are critically endangered, threatened by illegal collection, and confiscated in alarming numbers in recent years. Robust population- and technique-specific hematology and biochemistry reference intervals are valuable yet heretofore missing tools for triage, rehabilitation, and reintroduction of confiscated radiated tortoises. We determined reference intervals in 120 previously confiscated, clinically healthy subadult radiated tortoises living under human care within their native habitat at the Tortoise Conservation Center (TCC). Specific analytes measured were manual packed cell volume, total solids, white blood cell (WBC) count and differentials, and biochemistry analytes using a point of care system. To evaluate the effects of different commonly used techniques on these analytes, we compared results between two venipuncture sites (subcarapacial sinus and brachial vein) and three different WBC quantification methods (Natt and Herrick, Leukopet, and slide estimate). Reference intervals were narrower for most analytes, and sodium and potassium were qualitatively higher in the TCC population compared to previously published values from radiated tortoises housed in North American institutions. Creatine kinase, aspartate aminotransferase, glucose and inorganic phosphorus were all significantly greater in brachial samples than in subcarapacial samples. There was poor agreement and evidence of constant and/or proportional bias between all WBC quantification methods. Differences based on time of sample collection were incidentally found in some analytes. These results highlight the need for considering technique, demographic, and environmental factors in creating and applying reference intervals, and contribute foundational knowledge for improving care of radiated tortoises throughout the confiscation-to-release pathway.Entities:
Mesh:
Substances:
Year: 2022 PMID: 35286335 PMCID: PMC8920285 DOI: 10.1371/journal.pone.0264111
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Subadult radiated tortoise hematology reference intervals and descriptive statistics based on clinically healthy individuals living in a rehabilitation setting within their natural range.
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PCV (L/L) | 120 | 0.23 | 0.03 | 0.22 | 0.18 | 0.32 | 0.001 | NG | NP | 0.18–0.30 | 0.18–0.19 | 0.27–0.32 | N/A |
|
| |||||||||||||
| Total WBC (109/L) | 119 | 7.50 | 2.43 | 7.44 | 2.11 | 13.32 | 0.470 | G | R | 2.59–12.27 | 1.98–3.16 | 11.58–12.91 | 1 outlier |
| Heterophil (109/L) | 110 | 1.63 | 1.00 | 1.41 | 0.11 | 5.82 | <0.001 | NG | RT | 0.33–4.20 | 0.26–0.43 | 3.56–4.94 | 2 outliers |
| Lymphocyte (109/L) | 110 | 4.66 | 1.82 | 4.56 | 1.15 | 11.19 | 0.092 | NG | RT | 1.66–8.72 | 1.43–1.96 | 8.03–9.39 | 2 outliers |
| Monocyte (109/L) | 110 | 0.46 | 0.31 | 0.41 | 0.04 | 1.70 | <0.001 | NG | NP | 0.06–1.21 | 0.04–0.07 | 1.02–1.70 | 2 outliers |
| Eosinophil (109/L) | 110 | 0.22 | 0.21 | 0.17 | 0.00 | 1.18 | <0.001 | NG | NP | 0.00–0.81 | 0.00–0.00 | 0.63–1.18 | 2 outliers |
| Basophil (109/L) | 110 | 0.58 | 0.43 | 0.48 | 0.00 | 1.91 | <0.001 | NG | NP | 0.03–1.73 | 0.00–0.06 | 1.41–1.91 | 2 outliers |
|
| |||||||||||||
| Total WBC (109/L) | 110 | 8.76 | 5.03 | 7.85 | 0.87 | 26.19 | <0.001 | NG | NP | 2.00–22.89 | 0.87–3.16 | 18.92–26.19 | 1 outlier |
| Heterophil (109/L) | 102 | 1.63 | 0.91 | 1.41 | 0.50 | 5.76 | <0.001 | NG | NP | 0.66–4.84 | 0.50–0.73 | 3.35–5.76 | 2 outliers |
| Lymphocyte (109/L) | 102 | 5.59 | 3.88 | 4.23 | 0.82 | 18.59 | <0.001 | NG | NP | 1.19–16.53 | 0.82–1.50 | 14.33–18.59 | 2 outliers |
| Monocyte (109/L) | 102 | 0.52 | 0.45 | 0.36 | 0.04 | 1.97 | <0.001 | NG | RT | 0.07–1.97 | 0.05–0.08 | 1.56–2.48 | 2 outliers |
| Eosinophil (109/L) | 102 | 0.21 | 0.19 | 0.17 | 0.00 | 0.90 | <0.001 | NG | NP | 0.00–0.83 | 0.00–0.00 | 0.60–0.90 | 2 outliers |
| Basophil (109/L) | 102 | 0.63 | 0.58 | 0.49 | 0.00 | 3.45 | <0.001 | NG | NP | 0.02–2.54 | 0.00–0.05 | 1.69–3.45 | 2 outliers |
|
| |||||||||||||
| Total WBC (109/L) | 107 | 11.15 | 3.41 | 10.72 | 4.80 | 21.12 | 0.001 | NG | NP | 5.60–20.62 | 4.80–6.40 | 17.88–21.12 | 1 outlier |
| Heterophil (109/L) | 106 | 2.43 | 1.59 | 2.09 | 0.32 | 9.72 | <0.000 | NG | NP | 0.61–7.33 | 0.32–0.84 | 5.57–9.72 | 2 outliers |
| Lymphocyte (109/L) | 106 | 6.88 | 2.38 | 6.63 | 1.23 | 17.61 | 0.042 | NG | NP | 3.09–12.16 | 1.23–3.92 | 10.31–17.61 | 2 outliers |
| Monocyte (109/L) | 106 | 0.68 | 0.47 | 0.61 | 0.06 | 2.40 | <0.001 | NG | R | 0.08–1.95 | 0.06–0.12 | 1.69–2.22 | 2 outliers |
| Eosinophil (109/L) | 106 | 0.30 | 0.26 | 0.24 | 0.00 | 1.05 | <0.001 | NG | NP | 0.00–0.99 | 0.00–0.00 | 0.92–1.05 | 2 outliers |
| Basophil (109/L) | 106 | 0.86 | 0.69 | 0.65 | 0.00 | 4.51 | <0.001 | NG | NP | 0.04–2.83 | 0.00–0.11 | 2.08–4.51 | 2 outliers |
|
| |||||||||||||
| Heterophil | 111 | 0.21 | 0.10 | 0.19 | 0.05 | 0.46 | <0.001 | NG | NP | 0.07–0.44 | 0.05–0.09 | 0.39–0.46 | 1 outlier |
| Lymphocyte | 111 | 0.62 | 0.13 | 0.64 | 0.22 | 0.88 | 0.063 | NG | NP | 0.36–0.84 | 0.22–0.41 | 0.80–0.88 | 1 outlier |
| Monocyte | 111 | 0.06 | 0.04 | 0.06 | 0.01 | 0.17 | <0.001 | NG | NP | 0.01–0.20 | 0.01–0.01 | 0.13–0.17 | 1 outlier |
| Eosinophil | 111 | 0.03 | 0.02 | 0.03 | 0.00 | 0.12 | <0.001 | NG | NP | 0.00–0.10 | 0.00–0.00 | 0.07–0.12 | 1 outlier |
| Basophil | 111 | 0.08 | 0.05 | 0.07 | 0.00 | 0.22 | 0.001 | NG | NP | 0.01–0.20 | 0.00–0.01 | 0.18–0.22 | 1 outlier |
| Het:Lymph Ratio | 111 | 0.39 | 0.26 | 0.31 | 0.06 | 1.56 | <0.001 | NG | NP | 0.08–1.09 | 0.06–0.13 | 0.90–1.56 | 1 outlier |
CI = confidence interval, Dist. = distribution, G = Gaussian, hem = hemolysis (0, 1+, 2+, 3+), Het:Lymph = heterophil:lymphocyte, LRL = lower reference limit, NG = Non-Gaussian, NP = Non-parametric, p = Anderson-Darling p value, R = Robust, RT = Robust on Box Cox transformed data, SD = standard deviation, URL = upper reference limit, WBC = white blood cell. α = 0.3 for distribution tests per ASVCP Guidelines 2020. Samples sizes vary between and within methods as samples were excluded from affected analyses based on slide and Leukopet quality issues in addition to the presence of outliers.
Subadult radiated tortoise biochemistry reference intervals and descriptive statistics based on clinically healthy individuals living in a rehabilitation setting within their natural range.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TS (g/L) | All | 120 | 38 | 7 | 39 | 23 | 58 | 0.012 | NG | NP | 25–51 | 23–27 | 48–58 | N/A |
| TP (g/L) | All | 120 | 29 | 5 | 29 | 19 | 43 | 0.210 | NG | NP | 19–42 | 19–21 | 37–43 | N/A |
| AST (U/L) | All | 120 | 81 | 43 | 68 | 31 | 342 | <0.001 | NG | NP | 39–218 | 31–44 | 166–342 | N/A |
| AST (U/L) | SC | 80 | 74 | 34 | 65 | 31 | 245 | <0.001 | NG | NP | 38–209 | 31–41 | 120–245 | N/A |
| AST (U/L) | Br | 40 | 95 | 55 | 81 | 47 | 342 | <0.001 | NG | NP | 47–339 | 47–51 | 194–342 | N/A |
| CK (U/L) | All | 53 | 660 | 626 | 487 | 193 | 4011 | <0.001 | NG | RT | 201–2455 | 184–229 | 1726–3618 | time to analysis ≥ 5 hrs; |
| CK (U/L) | SC | 39 | 478 | 235 | 452 | 193 | 1358 | 0.008 | NG | RT | 190–1072 | 0–211 | 898–1281 | time to analysis ≥ 5 hrs; |
| CK (U/L) | Br | 14 | 1165 | 1016 | 912 | 310 | 4011 | 0.008 | NG | N/A | N/A | N/A | N/A | time to analysis ≥ 5 hrs; |
| Uric acid (μmol/L) | All | 120 | 23 | 8 | 17 | 17 | 48 | <0.001 | NG | NP | 17–42 | 17–17 | 42–48 | N/A |
| Glucose (mmol/L) | All | 90 | 3.2 | 0.7 | 3.2 | 1.9 | 5.8 | 0.477 | G | R | 1.8–4.5 | 1.6–2.1 | 4.2–4.7 | time to analysis ≥ 5 hrs |
| Glucose (mmol/L) | SC | 57 | 2.9 | 0.6 | 2.9 | 1.9 | 4.1 | 0.417 | G | R | 1.8–4.0 | 1.7–2.1 | 3.8–4.2 | time to analysis ≥ 5 hrs |
| Glucose (mmol/L) | Br | 33 | 3.6 | 0.7 | 3.6 | 2.0 | 5.8 | 0.183 | NG | RT | 2.3–5.2 | 2.1–2.7 | 4.6–5.7 | time to analysis ≥ 5 hrs |
| Total Ca (mmol/L) | All | 120 | 2.97 | 0.32 | 2.94 | 2.15 | 4.02 | 0.049 | NG | NP | 2.35–3.72 | 2.15–2.40 | 3.44–4.02 | N/A |
| Phos (mmol/L) | All | 120 | 1.03 | 0.23 | 1.00 | 0.71 | 1.81 | <0.001 | NG | NP | 0.74–1.61 | 0.71–0.77 | 1.49–1.81 | N/A |
| Phos (mmol/L) | SC | 80 | 1.00 | 0.16 | 0.97 | 0.71 | 1.52 | 0.001 | NG | NP | 0.74–1.49 | 0.71–0.77 | 1.32–1.52 | N/A |
| Phos (mmol/L) | Br | 40 | 1.10 | 0.26 | 1.07 | 0.74 | 1.81 | <0.001 | NG | NP | 0.74–1.81 | 0.74–0.77 | 1.61–1.81 | N/A |
| Ca:Phos Ratio | All | 120 | 3.9 | 0.8 | 3.8 | 2.1 | 5.7 | 0.639 | G | R | 2.3–5.4 | 2.1–2.5 | 5.2–5.6 | N/A |
| Ca:Phos Ratio | SC | 80 | 4.0 | 0.8 | 3.9 | 2.2 | 5.7 | 0.609 | G | R | 2.5–5.5 | 2.3–2.7 | 5.3–5.7 | N/A |
| Ca:Phos Ratio | Br | 40 | 3.6 | 0.8 | 3.5 | 2.1 | 5.2 | 0.858 | G | R | 2.0–5.2 | 1.7–2.4 | 4.9–5.5 | N/A |
| K (mmol/L) | All | 77 | 6.4 | 0.9 | 6.5 | 4.3 | 8.4 | 0.553 | G | R | 4.5–8.2 | 4.2–4.8 | 7.9–8.5 | time to analysis ≥ 8 hrs |
| Na (mmol/L) | All | 120 | 145 | 11 | 144 | 124 | 169 | 0.001 | NG | NP | 128–168 | 124–130 | 166–169 | N/A |
Results stratified by venipuncture site where statistically significant differences were found via generalized linear models. AST = aspartate transaminase, Br = brachial, Ca = calcium, CI = confidence interval, CK = creatine kinase, Dist. = distribution, G = Gaussian, hem = hemolysis (0, 1+, 2+, 3+), K = potassium, LRL = lower reference limit, Na = sodium, NG = Non-Gaussian, NP = Non-parametric, p = Anderson-Darling p-value, Phos = phosphorus, R = Robust, RT = Robust on Box Cox transformed data, SC = subcarapacial, SD = standard deviation, time to analysis = time from sample collection to biochemistry analysis, TP = total protein, TS = total solids, UA = uric acid, URL = upper reference limit, VS = venipuncture site. α = 0.3 for distribution tests per ASVCP Guidelines 2020.
Effects of venipuncture site, hemolysis, and time from sample collection to biochemistry analysis on hematology and biochemistry analytes in clinically healthy subadult radiated tortoises living in a rehabilitation setting within their natural range.
| RESPONSE | PREDICTORS | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Venipuncture site: Br (ref = SC) | Hemolysis: 1+ (ref = 0) | Hemolysis: 2+ (ref = 0) | Venipuncture time: PM (ref = AM) | Time to chemistry analysis (hrs) | ||||||
|
| β |
| β |
| β |
| β |
| β |
|
| AST (U/L) | 19.9 (3.35–36.5) | 0.018 | - | - | - | - | 12.11 (-12.8–37.0) | 0.700 | 0.401 (-2.59–6.03) | 0.359 |
| CK (U/L) | 893 (564–1220) | <0.001 | 356 (33.1–679) | 0.031 | 1021 (587–1456) | <0.001 | -166 (-652–319) | 0.502 | -93.3 (-176–-10.9) | 0.026 |
| Glucose (mmol/L) | 0.630 (0.410–0.851) | <0.001 | - | - | - | - | - | - | -0.102 (-0.159–-0.0448) | <0.001 |
| Total Ca (mmol/L) | - | - | -6.28e4 (-0.126–0.124) | 0.992 | -0.149 (-0.307–9.85e3) | 0.066 | -0.226 (-0.406–-0.0471) | 0.013 | - | - |
| Phos (mmol/L) | 0.107 (0.0222–0.191) | 0.013 | 0.0747 (-9.31e3–0.159) | 0.081 | 0.0960 (-0.0155–0.208) | 0.091 | -0.0394 (-0.160–0.0813) | 0.522 | 8.59e3 (-0.0124–0.0296) | 0.422 |
| K (mmol/L) | - | - | -0.128 (-0.556–0.304) | 0.562 | 0.352 (-0.191–0.896) | 0.204 | 1.06 (0.431–1.68) | <0.001 | 0.110 (0.00293–0.217) | 0.044 |
| Heterophils | - | - | - | - | - | - | 0.0769 (0.0153–0.139) | 0.016 | N/A | N/A |
| Lymphocytes | 0.0301 (0.0200–0.0802) | 0.239 | - | - | - | - | -0.111 (-0.191–-0.0315) | 0.006 | N/A | N/A |
| Het:Lymph Ratio† | -0.0948 (-0.359–0.170) | 0.482 | - | - | - | - | 0.580 (0.161–1.000) | 0.007 | N/A | N/A |
Results presented are the average of the best fit univariate generalized linear models (ΔAICc < 2) for each response analyte. Only models containing statistically significant predictors are presented. Br = brachial, AST = aspartate transaminase, Ca = calcium, CI = confidence interval, CK = creatine kinase, K = potassium, Na = sodium, p = Wald Z p-value, Phos = phosphorus, ref = reference value of categorical predictors, SC = subcarapacial,— = analyte not included in best fit model(s)
* = p < 0.05, † = analyte log transformed.
Fig 1Agreement between WBC quantification methods in clinically healthy, subadult radiated tortoises.
(a, c, e) Bland-Altman–solid line is the line of perfect agreement, dashed lines are mean difference between the methods (center), upper limit of agreement (upper), and lower limit of agreement (lower) with shading indicating associated 95% confidence intervals. (b, d) Passing-Bablok regression–dashed line is the line of perfect agreement, solid line is the regression line with shading indicating associated 95% confidence intervals. WBC = white blood cell.
Agreement between total white blood cell counts determined using the Natt and Herrick, Leukopet, and blood slide estimate methods in clinically healthy subadult radiated tortoises.
| Passing-Bablok | Bland-Altman | ||||||
|---|---|---|---|---|---|---|---|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Est vs. NH | 105 | 0.218 (0.001)* | -0.16 (-3.02–3.12) | 1.44 (1.03–1.83) | 3.51 (2.89–4.13) | -2.81 (-3.88–-1.74) | 9.83 (8.76–10.90) |
| Est vs. LP | 98 | 0.167 (0.016)* | 5.37 (3.10–7.52) | 0.685 (0.415–1.02) | 2.57 (1.49–3.66) | -8.04 (-9.90–-6.18) | 13.19 (11.33–15.05) |
| LP vs. NH | 109 | 0.017 (0.793) | N/A | N/A | 1.26 (0.21–2.30) | -9.53 (-11.32–-7.74) | 12.05 (10.25–13.84) |
A slope with a CI that does not include one indicates proportional bias and an intercept with a CI that does not include zero indicates constant bias. Bias = the mean difference between the two methods, CI = confidence interval, Est = blood slide estimate, * = p < 0.05, LOA = limit of agreement defined as the bias + 1.96 times the standard deviation of the differences, LP = Leukopet, N/A = estimates invalid due to lack of positive correlation based on Kendall’s Tau, NH = Natt and Herrick, * = p < 0.05. Intercept, bias, and LOAs reported in WBC x 109/L.